Literature DB >> 6697962

Characterization of precursor and secreted forms of rat angiotensinogen.

D J Campbell, J Bouhnik, E Coezy, F Pinet, E Clauser, J Menard, P Corvol.   

Abstract

Angiotensinogen precursors synthesized by rabbit reticulocyte lysate primed with rat liver RNA were compared with angiotensinogen secreted by rat hepatoma cells and rat hepatocytes using immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Inhibition of glycosylation with tunicamycin permitted identification of the nonglycosylated form of secreted angiotensinogen. Whereas angiotensinogen secreted by hepatoma cells and hepatocytes showed electrophoretic heterogeneity (mol wt, 52-62 X 10(3], tunicamycin-treated cells secreted only a single angiotensinogen species [mol wt, 48.3 +/- 0.7 X 10(3) (mean +/- SD)], which could be cleaved by renin. Two putative angiotensinogen precursors were synthesized in the reticulocyte lysate: a major protein of 52.5 +/- 1.0 X 10(3) mol wt and a minor protein of 55.7 +/- 1.3 X 10(3) mol wt. Evidence that these proteins represent separate angiotensinogen precursors includes the following. 1) Both proteins were recognized by five different polyclonal antibodies and two monoclonal antibodies. 2) Both proteins increased in parallel in reticulocyte lysates primed with liver RNA from rats nephrectomized and given hormones that increase liver angiotensinogen production. 3) Both proteins were cleaved by renin to produce a single protein of 47.6 +/- 0.8 X 10(3) mol wt. 4) The des-angiotensin I-angiotensinogen generated by renin treatment of the lysate had an electrophoretic mobility identical to that of des-AI-angiotensinogen produced by renin treatment of nonglycosylated angiotensinogen secreted by tunicamycin-treated hepatoma cells and hepatocytes. These studies suggest that rat liver synthesizes two separate angiotensinogen precursors which may differ only in the size of their prepro sequence. The heterogeneity of secreted angiotensinogen can be fully accounted for by differences in N-glycosylation of asparagine residues of the molecule. Glycosylation of angiotensinogen is not essential for its synthesis, processing, and secretion or its hydrolysis by renin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697962     DOI: 10.1210/endo-114-3-776

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Authors:  Congqing Wu; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  N Am J Med Sci (Boston)       Date:  2011-10-01

2.  Characterization of precursor and secreted forms of human angiotensinogen.

Authors:  D J Campbell; J Bouhnik; E Coezy; J Menard; P Corvol
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

3.  Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.

Authors:  D J Campbell; J F Habener
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Effects of glucocorticoids and antiglucocorticoid on angiotensinogen production by hepatoma cells in culture.

Authors:  E Coezy; J Bouhnik; E Clauser; F Pinet; M Philippe; J Menard; P Corvol
Journal:  In Vitro       Date:  1984-07

5.  Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice.

Authors:  W M Clouston; I G Lyons; R I Richards
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.